Gilead Sciences (NasdaqGS: GILD) may lead the race to offer an all-oral treatment for Hepatitis C liver disease, but several other drug companies are also in the hunt. Read More
Jim Fink is chief investment strategist for Options for Income, Velocity Trader, and Jim Fink's Inner Circle. He has traded options for more than 30 years and generated personal profits of more than $5 million. Jim also serves as an investment analyst at Investing Daily’s flagship investing publication, Personal Finance.
Hopelessly overeducated, Jim holds a bachelor's degree from Yale University, a master's degree from Harvard's Kennedy School of Government, a law degree from Columbia University, and an MBA from the University of Virginia's Darden School of Business. For good measure, he has been a member of the Illinois and D.C. bars.
Prior to joining Investing Daily, and when not incurring student loans hiding out in academe, Jim practiced telecommunications regulatory law for nine years until he realized that he made more money trading stock options than writing briefs. After attending business school, Jim switched gears to the investment realm full-time, working for a university endowment, a private wealth management firm, an insurance and financial planning company, and as a Senior Analyst for an online investment newsletter service that encourages the wearing of funny hats.
A possible but unlikely descendant of legendary brawler and boatman Mike Fink, Jim defies his heritage, believing that investing success requires patience and analysis, not swashbuckling bravado. Besides his passion for analyzing and writing about stocks, Jim likes to hike in the desert Southwest, vacation in Las Vegas, play tennis, and feed his toddler son Cheerios.
Analyst Articles
The stock market is near four-year highs, but that hasn't stopped some stocks from plunging. Jim discusses three such stocks, only one of which is a speculative buy. Read More
August means 13F filing season, which allows us to peek into the minds of the world's greatest investors. Consumer staples and technology are in, while Citigroup is out. Read More
If you are concerned about a market correction or worse, investing in companies that are influenced by women is a wise move. And you might outperform in bull markets, too! Read More
As a result of the market's strong uptrend, two of the three August covered calls need to be rolled at debits. Read More
Although the demands of motherhood in raising small children could detrimentally affect the performance of female CEOs, academic research points to a completely unrelated reason. Read More
- August 16, 2012
-
Download Issue
As one of the largest generators of electricity in the US, this utility has experienced a rise in share price as risk-averse investors seek dividend-paying companies that offer essential services. Once its shares eventually revert to trading at a more rational level, the income generated from selling a covered call should offset some of that decline. Read More
- August 16, 2012
-
Download Issue
This top global producer of spirits could soon find its growth impaired by a slowdown in the developed world. With shares of its stock likely at a near-term peak, long-term investors can get paid to bide their time by selling a covered call. Read More
Is it a good idea for mothers with young children to work full-time? When the salary is more than $100 million, the answer is probably yes. Read More
The Federal Reserve's policy statement on August 1st suggests that Quantitative Easing Part 3 (QE3) may be just around the corner. Read More